Rare pediatric PRV reauthorization faces uncertain fate as summer recess approaches
With the summer recess for Congress approaching, lawmakers will have to move quickly in the early fall if they’re going to reauthorize an FDA voucher …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
